| [1] |
Lee HJ, Kim MJ, Choi JY, et al. Relative accuracy of CT and MRI in the differentiation of benign from malignant pancreatic cystic lesions[J]. Clin Radiol, 2011, 66(4): 315-321.
|
| [2] |
Del Chiaro M, Verbeke C, Salvia R, et al. European experts consensus statement on cystic tumours of the pancreas[J]. Dig Liver Dis, 2013, 45(9): 703-711.
|
| [3] |
van Huijgevoort N, Del Chiaro M, Wolfgang CL, et al. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(11): 676-689.
|
| [4] |
Dumonceau JM, Deprez PH, Jenssen C, et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical guideline-updated January 2017[J]. Endoscopy, 2017, 49(7): 695-714.
|
| [5] |
Bick BL, Enders FT, Levy MJ, et al. The string sign for diagnosis of mucinous pancreatic cysts[J]. Endoscopy, 2015, 47(7): 626-631.
|
| [6] |
Leung KK, Ross WA, Evans D, et al. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management[J]. Ann Surg Oncol, 2009, 16(10): 2818-2824.
|
| [7] |
Pitman MB, Lewandrowski K, Shen J, et al. Pancreatic cysts: preoperative diagnosis and clinical management[J]. Cancer Cytopathol, 2010, 118(1): 1-13.
|
| [8] |
de Jong K, Poley JW, van Hooft JE, et al. Endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions provides inadequate material for cytology and laboratory analysis: initial results from a prospective study[J]. Endoscopy, 2011, 43(7): 585-590.
|
| [9] |
Thornton GD, McPhail MJ, Nayagam S, et al. Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: A meta-analysis[J]. Pancreatology, 2013, 13(1): 48-57.
|
| [10] |
Thosani N, Thosani S, Qiao W, et al. Role of EUS-FNA-based cytology in the diagnosis of mucinous pancreatic cystic lesions: A systematic review and meta-analysis[J]. Dig Dis Sci, 2010, 55(10): 2756-2766.
|
| [11] |
Okasha HH, Ashry M, Imam HM, et al. Role of endoscopic ultrasound-guided fine needle aspiration and ultrasound-guided fine-needle aspiration in diagnosis of cystic pancreatic lesions[J]. Endosc Ultrasound, 2015, 4(2): 132-136.
|
| [12] |
Bruno M, Bosco M, Carucci P, et al. Preliminary experience with a new cytology brush in EUS-guided FNA[J]. Gastrointest Endosc, 2009, 70(6): 1220-1224.
|
| [13] |
Barresi L, Tarantino I, Traina M, et al. Endoscopic ultrasound-guided fine needle aspiration and biopsy using a 22-gauge needle with side fenestration in pancreatic cystic lesions[J]. Dig Liver Dis, 2014, 46(1): 45-50.
|
| [14] |
Yang D, Trindade AJ, Yachimski P, et al. Histologic analysis of endoscopic ultrasound-guided through the needle microforceps biopsies accurately identifies mucinous pancreas cysts[J]. Clin Gastroenterol Hepatol, 2019, 17(8): 1587-1596.
|
| [15] |
Vilas-Boas F, Macedo G. Pancreatic cystic lesions: new endoscopic trends in diagnosis[J]. J Clin Gastroenterol, 2018, 52(1): 13-19.
|
| [16] |
Brugge WR, Lauwers GY, Sahani D, et al. Cystic neoplasms of the pancreas[J]. N Engl J Med, 2004, 351(12): 1218-1226.
|
| [17] |
Park WG, Wu M, Bowen R, et al. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine[J]. Gastrointest Endosc, 2013, 78(2): 295-302, e2.
|
| [18] |
Shi J, Yi Z, Jin L, et al. Cyst fluid metabolites distinguish malignant from benign pancreatic cysts[J]. Neoplasia, 2021, 23(11): 1078-1088.
|
| [19] |
Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: A report of the cooperative pancreatic cyst study[J]. Gastroenterology, 2004, 126(5): 1330-1336.
|
| [20] |
Tanaka M, Fernández-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas[J]. Pancreatology, 2017, 17(5): 738-753.
|
| [21] |
European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms[J]. Gut, 2018, 67(5): 789-804.
|
| [22] |
Gaddam S, Ge PS, Keach JW, et al. Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study[J]. Gastrointest Endosc, 2015, 82(6): 1060-1069.
|
| [23] |
Park WG, Mascarenhas R, Palaez-Luna M, et al. Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts[J]. Pancreas, 2011, 40(1): 42-45.
|
| [24] |
Khalid A, Zahid M, Finkelstein SD, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: A report of the PANDA study[J]. Gastrointest Endosc, 2009, 69(6): 1095-1102.
|
| [25] |
van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: A pooled analysis[J]. Gastrointest Endosc, 2005, 62(3): 383-389.
|
| [26] |
Hammel P, Levy P, Voitot H, et al. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas[J]. Gastroenterology, 1995, 108(4): 1230-1235.
|
| [27] |
Frossard JL, Amouyal P, Amouyal G, et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions[J]. Am J Gastroenterol, 2003, 98(7): 1516-1524.
|
| [28] |
Wang Y, Chai N, Feng J, et al. A prospective study of endoscopic ultrasonography features, cyst fluid carcinoembryonic antigen, and fluid cytology for the differentiation of small pancreatic cystic neoplasms[J]. Endosc Ultrasound, 2018, 7(5): 335-342.
|
| [29] |
Snozek CL, Mascarenhas RC, O'Kane DJ. Use of cyst fluid CEA, CA19-9, and amylase for evaluation of pancreatic lesions[J]. Clin Biochem, 2009, 42(15): 1585-1588.
|
| [30] |
Zikos T, Pham K, Bowen R, et al. Cyst fluid glucose is rapidly feasible and accurate in diagnosing mucinous pancreatic cysts[J]. Am J Gastroenterol, 2015, 110(6): 909-914.
|
| [31] |
Carr RA, Yip-Schneider MT, Simpson RE, et al. Pancreatic cyst fluid glucose: rapid, inexpensive, and accurate diagnosis of mucinous pancreatic cysts[J]. Surgery, 2018, 163(3): 600-605.
|
| [32] |
Kadayifci A, Al-Haddad M, Atar M, et al. The value of KRAS mutation testing with CEA for the diagnosis of pancreatic mucinous cysts[J]. Endosc Int Open, 2016, 4(4): E391-E396.
|
| [33] |
Nikiforova MN, Khalid A, Fasanella KE, et al. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: A clinical experience of 618 pancreatic cysts[J]. Mod Pathol, 2013, 26(11): 1478-1487.
|
| [34] |
Wu J, Jiao Y, Dal Molin M, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways[J]. Proc Natl Acad Sci U S A, 2011, 108(52): 21188-21193.
|
| [35] |
Jimenez RE, Warshaw AL, Z’graggen K, et al. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy[J]. Ann Surg, 1999, 230(4): 501-509.
|
| [36] |
Tan MC, Basturk O, Brannon AR, et al. GNAS and KRAS mutations define separate progression pathways in intraductal papillary mucinous neoplasm-associated carcinoma[J]. J Am Coll Surg, 2015, 220(5): 845-854, e1.
|
| [37] |
Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development[J]. Sci Transl Med, 2011, 3(92): 92ra66.
|
| [38] |
Springer S, Wang Y, Dal Molin M, et al. A combination of molecular markers and clinical features improve the classification of pancreatic cysts[J]. Gastroenterology, 2015, 149(6): 1501-1510.
|
| [39] |
Siddiqui AA, Kowalski TE, Kedika R, et al. EUS-guided pancreatic fluid aspiration for DNA analysis of KRAS and GNAS mutations for the evaluation of pancreatic cystic neoplasia: A pilot study[J]. Gastrointest Endosc, 2013, 77(4): 669-670.
|
| [40] |
Molin MD, Matthaei H, Wu J, et al. Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas[J]. Ann Surg Oncol, 2013, 20(12): 3802-3808.
|
| [41] |
Singhi AD, Nikiforova MN, Fasanella KE, et al. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts[J]. Clin Cancer Res, 2014, 20(16): 4381-4389.
|
| [42] |
McCarty TR, Paleti S, Rustagi T. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: A systematic review and meta-analysis[J]. Gastrointest Endosc, 2021, 93(5): 1019-1033, e5.
|
| [43] |
Kadayifci A, Atar M, Wang JL, et al. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms[J]. Dig Endosc, 2017, 29(1): 111-117.
|
| [44] |
Macgregor-Das AM, Iacobuzio-Donahue CA. Molecular pathways in pancreatic carcinogenesis[J]. J Surg Oncol, 2013, 107(1): 8-14.
|
| [45] |
Amato E, Molin MD, Mafficini A, et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas[J]. J Pathol, 2014, 233(3): 217-227.
|
| [46] |
Huang B, Trujillo MA, Fujikura K, et al. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms[J]. J Pathol, 2020, 252(3): 252-262.
|
| [47] |
Fischer CG, Beleva Guthrie V, Braxton AM, et al. Intraductal papillary mucinous neoplasms arise from multiple independent clones, each with distinct mutations[J]. Gastroenterology, 2019, 157(4): 1123-1137, e22.
|
| [48] |
Singhi AD, Zeh HJ, Brand RE, et al. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: A clinicopathologic study of 225 patients with supporting molecular data[J]. Gastrointest Endosc, 2016, 83(6): 1107-1117, e2.
|
| [49] |
Tamura K, Nishimori I, Ito T, et al. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease[J]. World J Gastroenterol, 2010, 16(36): 4515-4518.
|
| [50] |
Ryu JK, Matthaei H, Dal Molin M, et al. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma[J]. Pancreatology, 2011, 11(3): 343-350.
|
| [51] |
Caponi S, Funel N, Frampton AE, et al. The good, the bad and the ugly: A tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms[J]. Ann Oncol, 2013, 24(3): 734-741.
|
| [52] |
Henry JC, Bassi C, Giovinazzo F, et al. MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas[J]. Ann Surg Oncol, 2013, 20 Suppl 3: S661-S666.
|
| [53] |
Cao Z, Maupin K, Curnutte B, et al. Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts[J]. Mol Cell Proteomics, 2013, 12(10): 2724-2734.
|
| [54] |
Haab BB, Porter A, Yue T, et al. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms[J]. Ann Surg, 2010, 251(5): 937-945.
|
| [55] |
Jabbar KS, Verbeke C, Hyltander AG, et al. Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer[J]. J Natl Cancer Inst, 2014, 106(2): djt439.
|